Cineverse Corp. (NASDAQ:CNVS - Get Free Report) was the target of a large decrease in short interest in the month of February. As of February 27th, there was short interest totaling 540,657 shares, a decrease of 39.2% from the February 12th total of 889,859 shares. Currently, 2.9% of the shares of the stock are sold short. Based on an average trading volume of 581,051 shares, the short-interest ratio is currently 0.9 days. Based on an average trading volume of 581,051 shares, the short-interest ratio is currently 0.9 days. Currently, 2.9% of the shares of the stock are sold short.
Cineverse Stock Performance
Shares of NASDAQ CNVS traded down $0.10 during midday trading on Friday, hitting $2.60. 120,654 shares of the company traded hands, compared to its average volume of 287,791. Cineverse has a 12-month low of $1.77 and a 12-month high of $7.39. The firm has a market cap of $55.38 million, a P/E ratio of -4.91 and a beta of 1.55. The stock has a 50-day moving average price of $2.40 and a 200 day moving average price of $2.80.
Cineverse (NASDAQ:CNVS - Get Free Report) last posted its quarterly earnings data on Tuesday, February 17th. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.02). The firm had revenue of $16.29 million for the quarter, compared to the consensus estimate of $20.00 million. Cineverse had a negative net margin of 16.67% and a negative return on equity of 27.40%.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on CNVS shares. Alliance Global Partners reaffirmed a "buy" rating on shares of Cineverse in a research note on Wednesday, February 18th. Benchmark restated a "speculative buy" rating on shares of Cineverse in a report on Monday, November 17th. Finally, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Cineverse in a research report on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and an average price target of $9.00.
Check Out Our Latest Research Report on CNVS
Insiders Place Their Bets
In related news, insider Yolanda Macias bought 30,000 shares of the stock in a transaction that occurred on Tuesday, February 17th. The shares were acquired at an average cost of $2.00 per share, with a total value of $60,000.00. Following the completion of the purchase, the insider directly owned 121,760 shares of the company's stock, valued at $243,520. This trade represents a 32.69% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Erick Opeka acquired 30,000 shares of the stock in a transaction dated Tuesday, February 17th. The shares were bought at an average price of $2.00 per share, for a total transaction of $60,000.00. Following the transaction, the insider owned 224,146 shares in the company, valued at approximately $448,292. This represents a 15.45% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders bought 187,500 shares of company stock worth $375,000. Company insiders own 13.30% of the company's stock.
Hedge Funds Weigh In On Cineverse
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Hillsdale Investment Management Inc. purchased a new position in shares of Cineverse during the second quarter valued at approximately $48,000. Sugar Maple Asset Management LLC purchased a new stake in shares of Cineverse in the 3rd quarter worth approximately $42,000. Kathmere Capital Management LLC bought a new position in Cineverse during the 3rd quarter valued at approximately $44,000. StoneX Group Inc. purchased a new position in Cineverse during the fourth quarter valued at $30,000. Finally, Prelude Capital Management LLC raised its stake in Cineverse by 31.1% during the third quarter. Prelude Capital Management LLC now owns 17,037 shares of the company's stock valued at $57,000 after buying an additional 4,037 shares during the last quarter. Institutional investors own 8.19% of the company's stock.
About Cineverse
(
Get Free Report)
Cineverse NASDAQ: CNVS, formerly known as Cinedigm, is a digital entertainment company that acquires, produces and distributes film and television content across a range of platforms. Through its streaming division, the company offers a portfolio of direct-to-consumer channels and apps—spanning genres such as horror, faith and family, documentaries and classic cinema—on both AVOD (ad-supported) and FAST (free ad-supported television) services. Cineverse also licenses its curated libraries to third-party streaming platforms, pay-TV operators and retail video-on-demand providers.
In addition to its consumer-facing streaming business, Cineverse operates a digital cinema network that supplies hardware, software and content delivery solutions to cinema exhibitors throughout North America.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cineverse, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cineverse wasn't on the list.
While Cineverse currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.